发布求助
文献互助 智能选刊 最新文献

Medical Letter on Drugs and Therapeutics最新文献

筛选
英文 中文
Inavolisib (Itovebi) for locally advanced or metastatic breast cancer. 治疗局部晚期或转移性乳腺癌的伊那韦利（Itovebi）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715f
{"title":"Inavolisib (Itovebi) for locally advanced or metastatic breast cancer.","authors":"","doi":"10.58347/tml.2024.1715f","DOIUrl":"https://doi.org/10.58347/tml.2024.1715f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Axatilimab (Niktimvo) for chronic graft-versus-host disease. 阿沙替利单抗（Niktimvo）治疗慢性移植物抗宿主病。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715e
{"title":"Axatilimab (Niktimvo) for chronic graft-versus-host disease.","authors":"","doi":"10.58347/tml.2024.1715e","DOIUrl":"https://doi.org/10.58347/tml.2024.1715e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Xanomeline/Trospium (Cobenfy) for schizophrenia. 治疗精神分裂症的 Xanomeline/Trospium (Cobenfy)。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715a
{"title":"Xanomeline/Trospium (Cobenfy) for schizophrenia.","authors":"","doi":"10.58347/tml.2024.1715a","DOIUrl":"https://doi.org/10.58347/tml.2024.1715a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lebrikizumab (Ebglyss) for atopic dermatitis. 治疗特应性皮炎的 Lebrikizumab（Ebglyss）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715b
{"title":"Lebrikizumab (Ebglyss) for atopic dermatitis.","authors":"","doi":"10.58347/tml.2024.1715b","DOIUrl":"https://doi.org/10.58347/tml.2024.1715b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vorasidenib (Voranigo) for low-grade glioma. 治疗低级别胶质瘤的 Vorasidenib（Voranigo）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715g
{"title":"Vorasidenib (Voranigo) for low-grade glioma.","authors":"","doi":"10.58347/tml.2024.1715g","DOIUrl":"https://doi.org/10.58347/tml.2024.1715g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risankizumab (Skyrizi) for ulcerative colitis. 治疗溃疡性结肠炎的利桑珠单抗（Skyrizi）。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715d
{"title":"Risankizumab (Skyrizi) for ulcerative colitis.","authors":"","doi":"10.58347/tml.2024.1715d","DOIUrl":"https://doi.org/10.58347/tml.2024.1715d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eroxon - an OTC gel for erectile dysfunction. Eroxon - 治疗勃起功能障碍的非处方药凝胶。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715c
{"title":"Eroxon - an OTC gel for erectile dysfunction.","authors":"","doi":"10.58347/tml.2024.1715c","DOIUrl":"https://doi.org/10.58347/tml.2024.1715c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: A new non-small cell lung cancer indication for osimertinib (Tagrisso). 简而言之奥西替尼（Tagrisso）新增非小细胞肺癌适应症。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-11-11 DOI: 10.58347/tml.2024.1715h
{"title":"In brief: A new non-small cell lung cancer indication for osimertinib (Tagrisso).","authors":"","doi":"10.58347/tml.2024.1715h","DOIUrl":"https://doi.org/10.58347/tml.2024.1715h","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In brief: FluMist influenza vaccine for self-administration. 简而言之：用于自我注射的 FluMist 流感疫苗。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714c
{"title":"In brief: FluMist influenza vaccine for self-administration.","authors":"","doi":"10.58347/tml.2024.1714c","DOIUrl":"https://doi.org/10.58347/tml.2024.1714c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 update: Novavax vaccine for 2024-2025. COVID-19 更新：2024-2025 年的 Novavax 疫苗。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2024-10-28 DOI: 10.58347/tml.2024.1714d
{"title":"COVID-19 update: Novavax vaccine for 2024-2025.","authors":"","doi":"10.58347/tml.2024.1714d","DOIUrl":"https://doi.org/10.58347/tml.2024.1714d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信